<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    Innovation Pharmaceuticals Inc.

    Innovation Pharmaceuticals Inc.

    Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pha...

    Established in 2007, and headquartered in Wakef...

    Filing Type:    PU
    MyoKardia, Inc.

    MyoKardia, Inc.

    MyoKardia is a clinical-stage biopharmaceutical company pioneering a precision med...

    MyoKardia is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company. We ...

    Corvus Pharmaceuticals is a clinical science-dr...

    Filing Type:    PU
    Urovant Sciences Ltd.

    Urovant Sciences Ltd.

    Urovant Sciences is a clinical-stage biopharmaceutical company focused on developi...

    Urovant Sciences is a clinical-stage biopharmac...

    Filing Type:    PU
    Nature's Sunshine Products, Inc.

    Nature's Sunshine Products, Inc.

    Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness ...

    Nature’s Sunshine Products (NASDAQ:NATR), a l...

    Filing Type:    PU
    Vaccinex, Inc.

    Vaccinex, Inc.

    Vaccinex is a clinical-stage biotechnology company engaged in the discovery and de...

    Vaccinex is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Aduro Biotech, Inc.

    Aduro Biotech, Inc.

    Aduro is dedicated to its mission to discover, develop, and commercialize immunoth...

    Aduro is dedicated to its mission to discover, ...

    Filing Type:    PU
    Arvinas, Inc.

    Arvinas, Inc.

    Arvinas is a biopharmaceutical company dedicated to improving the lives of patient...

    Arvinas is a biopharmaceutical company dedicate...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.